Adalimumab-ATTO
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13550 publications
Adalimumab-induced pustular psoriasis successfully treated with tofacitinib in a patient with ankylosing spondylitis: A brief report.
Journal: JAAD case reports
Published: October 29, 2026
Uncovering the full economic impact of biosimilars: a "would have spent" counterfactual analysis of five reference biologics (infliximab, adalimumab, bevacizumab, rituximab, and trastuzumab) in the United States and Europe, 2016-2025.
Journal: Journal of medical economics
Published: October 28, 2026
Relapse during long-term adalimumab treatment in intestinal Behçet's disease.
Journal: BMJ case reports
Published: October 28, 2026
Engineering the synovial lining-sublining architecture in a human 3D model to study macrophage-fibroblast interactions in arthritis.
Journal: Biofabrication
Published: October 27, 2026
Biosimilars in inflammatory bowel disease: from initial uncertainty to clinical normalization.
Journal: Revista espanola de enfermedades digestivas
Published: October 26, 2026
Reappraisal of Comparison of the Efficacy and Safety of Biosimilar Adalimumab with Innovator Adalimumab in Ankylosing Spondylitis.
Journal: The Journal of the Association of Physicians of India
Published: October 22, 2026
Nerandomilast treatment improves a case of progressive pulmonary fibrosis combined with severe plaque psoriasis: A case report from a clinical trial.
Journal: Therapeutic advances in respiratory disease
Published: October 22, 2026
Adalimumab durability in hidradenitis suppurativa: persistence is not synonymous with sustained response.
Journal: The Journal of dermatological treatment
Published: October 19, 2026
Second-generation lectin microarray for high throughput glycan profiling of therapeutic antibodies.
Journal: AAPS open
Published: October 17, 2026
Advancing Our Understanding of Hidradenitis Suppurativa: A Comprehensive Guide for Clinicians Designed to Improve Therapeutic Outcomes for Patients-Part 2.
Journal: The Journal of clinical and aesthetic dermatology
Published: October 17, 2026
Tumor Necrosis Factor-Alpha Inhibitors: Oral Health and Orthodontic Considerations.
Journal: Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995)
Published: October 13, 2026
Comparative drug survival of biologic classes in psoriasis: a Japanese single-centre cohort study.
Journal: European journal of dermatology : EJD
Published: October 12, 2026
Last Updated: 11/08/2026